Table 3.
Univariate Cox regression analysis for the evaluated BCA parameters.
| Covariate | HR | 95% CI | p value | |
|---|---|---|---|---|
| SM normalized∗ | Continuous | 0.9 | 0.8–0.9 | <0.001 |
| TAT normalized∗ | Continuous | 0.9 | 0.8–1.0 | 0.013 |
| IMAT normalized∗ | Continuous | 1.0 | 0.9–1.0 | 0.310 |
| SAT normalized∗ | Continuous | 0.9 | 0.8–1.0 | 0.006 |
| VAT normalized∗ | Continuous | 0.9 | 0.9–1.0 | 0.150 |
| SM/Bone (MBR) | Continuous | 0.7 | 0.6–0.8 | <0.001 |
| TAT/Bone | Continuous | 0.9 | 0.9–1.0 | 0.022 |
| IMAT/Bone | Continuous | 0.1 | 0.0–92 | 0.300 |
| SAT/Bone | Continuous | 0.3 | 0.1–1.0 | 0.057 |
| VAT/Bone | Continuous | 0.4 | 0.1–2.3 | 0.280 |
| Sarcopenia marker | Continuous | 0.7 | 0.6–0.9 | <0.001 |
| SM/height2∗∗ | Continuous | 1.0 | 0.9–1.0 | 0.0118 |
| TAT/height2∗∗ | Continuous | 1.0 | 1.0–1.0 | 0.011 |
| IMAT/height2∗∗ | Continuous | 0.5 | 0.1–1.6 | 0.210 |
| SAT/height2∗∗ | Continuous | 0.8 | 0.6–0.9 | 0.009 |
| VAT/height2∗∗ | Continuous | 0.8 | 0.6–1.1 | 0.110 |
p values in bold show significant values.
BCA, body composition assessment; IMAT, intermuscular adipose tissue; SAT, subcutaneous adipose tissue; SM, skeletal muscle volume; TAT, total adipose tissue; VAT, visceral adipose tissue.
∗
Normalized on the slice thickness.
∗∗
Height only available in n = 522 patients.